Saturday 17 October 2026
Export COSM’s income statement to Excel — free account
Cosmos Health Inc.
COSM Healthcare Medical Distribution
Cosmos Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.3 million, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 28.8%, EPS was flat, free cash flow grew 9.39% and total debt rose 15.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
0.33
0.01
−2.94%
Follow COSM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 5 | 4 |
+8 more TTM periods Free account |
| (104.00%) | (92.32%) | (89.13%) | (63.82%) | ||
| (39.56%) | (35.35%) | (31.96%) | (27.67%) | ||
ROIC |
(38.23%) | (35.69%) | (34.86%) | (28.07%) | |
Return on Tangible Assets |
(203.83%) | (161.41%) | (179.00%) | (181.17%) | |
Average Days of Receivables |
105.16 | 107.96 | 123.43 | 119.88 | |
Free Cash Flow per Share |
(0.21) | (0.27) | (0.35) | (0.32) | |
Free Cash Flow |
(12.45) | (12.58) | (10.60) | (9.75) | |
Capital Expenditures |
(2.61) | (3.25) | (2.15) | (2.07) | |
| Other line items | |||||
Cash ROIC |
(35.64%) | (34.93%) | (28.68%) | (23.73%) | |
Accounts Receivable Turnover |
3.87 | 3.84 | 3.55 | 3.11 | |
Accounts Payable Turnover |
4.74 | 4.59 | 3.95 | 3.88 | |
Inventory Turnover |
13.74 | 11.99 | 11.32 | 10.02 | |
Average Days of Payables |
79.98 | 86.87 | 105.77 | 101.13 | |
Days of Inventory on Hand |
24.93 | 33.13 | 36.76 | 39.16 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.78% | 0.00% | 0.80% | 0.18% | |
Selling, General and Administrative Expense of Revenue |
32.36% | 33.41% | 34.54% | 31.42% | |
Share Based Compensation of Revenue |
3.05% | 3.30% | 3.54% | 3.87% | |
Interest Coverage |
(4.95) | (5.56) | (6.37) | (7.39) | |
Operating CF/Net income |
0.40 | 0.44 | 0.44 | 0.41 | |
Depreciation/Fixed assets |
0.14 | 0.14 | 0.13 | 0.13 | |
Capex/Depreciation |
(1.88) | (2.32) | (1.57) | (1.52) | |
Revenue per Share |
1.23 | 1.48 | 2.16 | 1.95 | |
Operating CF per Share |
(0.16) | (0.20) | (0.28) | (0.25) | |
Capex per Share |
(0.04) | (0.07) | (0.07) | (0.07) | |
Capex to Sales |
0.04 | 0.05 | 0.03 | 0.03 |
Columns are period end dates